Christoph Schumacher

Author

Also Known As

Alberto Ruol, C Schumacher, C. SCHUMACHER, C. Schumacher, Christoph D. Schumacher, Christoph Schumacher, Christoph Schumacher (Hrsg.), Greenberg, Barry, Schumacher, Christoph

114

Publications

3.9K

Citations

H-Index

102

Concepts

All Affiliations

Novartis (Switzerland)University of Bern Novartis (United States)Ludwig-Maximilians-Universität München Myriad Genetics

About

Christoph Schumacher is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	3.1K
2	Natural Sciences	4	4	670
3	Health Sciences	2	2	173
4	Education	1	1	24
5	Engineering	1	1	12

Christoph Schumacher

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial John R. Teerlink, Gad Cotter, Beth A. Davison, The Lancet Heart FailureCardiac AnaesthesiaCardiogenic ShockCardiovascular DiseasePharmacology	2012	896
Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program Marco Metra, Gad Cotter, Beth A. Davison, Journal of the American College of Cardiology Heart FailureStressMedicinePhysiologyCardiovascular Pharmacology	2012	423
Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. Ian Clark‐Lewis, Christoph Schumacher, Marco Baggiolini, Journal of Biological Chemistry ImmunologyImmune RegulationNh2-terminal ResiduesInnate ImmunityImmune System	1991	423
Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils Bernhard Moser, Christoph Schumacher, V von Tscharner, Journal of Biological Chemistry InflammationCytokineLigand Cross-linkingAutoimmune DiseaseGranulocyte	1991	222
High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Christoph Schumacher, Ian Clark‐Lewis, Marco Baggiolini, Proceedings of the National Academy of Sciences InflammationGro AlphaCytokineAnti-inflammatoryAutoimmune Disease	1992	197
A protein-binding domain, EH, identified in the receptor tyrosine kinase substrate Eps15 and conserved in evolution. Wai T. Wong, Christoph Schumacher, Anna Elisabetta Salcini, Proceedings of the National Academy of Sciences Protein FunctionSignal TransductionSignaling PathwayMedicineProtein-binding Domain	1995	140
Interleukin-8 antagonists generated by N-terminal modification. Bernhard Moser, Béatrice Dewald, Luca Barella, Journal of Biological Chemistry InflammationN-terminal ModificationCytokineAnti-inflammatoryIl-8 Function	1993	137
Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells Bernhard Moser, Luca Barella, Stefano Mattei, Biochemical Journal Immune RegulationImmunologyRetinoic AcidImmunologic MechanismCd4 T Cell Responses	1993	128
The SCAN Domain Mediates Selective Oligomerization Christoph Schumacher, Hubert Wang, Christian Honer, Journal of Biological Chemistry Protein FunctionFunctional GenomicsProtein AssemblyStructural BioinformaticsMedicine	2000	95
A Broad Role for the Zinc Finger Protein ZNF202 in Human Lipid Metabolism Susanne Wagner, Mark A. Hess, Patricia Ormonde-Hanson, Journal of Biological Chemistry GeneticsOxidative StressMetabolic SyndromeCandidate Susceptibility GeneProteomics	2000	94

Page 1